Fundraising Fox
Marianne Bjørdal
InvestorGeneral Partner at 3B Future Health Fund · Board director at Gain Therapeutics
France
Writes $100K – $5M checks · typically $1.5M
Find your path to Marianne
162 people in our graph can introduce you to Marianne.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Grita Loebsack to introduce you to Marianne
You →Grita · together at Virbac (2018) →Marianne
Ask Jamie Chen to introduce you to Marianne
You →Jamie · 3 people · together at Virbac →Marianne
Ask Sam Okafor to introduce you to Marianne
You →Sam · together at Sibylla →Marianne
Sign up to find every way you can get introduced to Marianne
- Your email: the people you already email who know Marianne
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Marianne
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Marianne Bjørdal is a Partner at 3B Future Health Ventures, part of the Helsinn Group. She has a background in life science research and investment management, with focus on drug development and early-stage ventures.
Board director at Gain Therapeutics
Intro paths
In turn, Marianne can intro founders to Gain Therapeutics's investors below.
Experience
- Helsinn Group -3B Future Health VenturesPartnercurrent2022 — present
- Helsinn Group -3B Future Health VenturesSenior Associate2019 — 2022
- Helsinn Group -3B Future Health VenturesInvestment Analyst2018 — 2019Monaco area
- Sibylla BiotechBoard Membercurrent2022 — present
- Epsilogen LtdBoard membercurrent2022 — present
- Kither BiotechBoard Observercurrent2022 — present
- Navion incBoard membercurrent2021 — present
- NeoPhore LtdBoard membercurrent2021 — present
- Gain TherapeuticsBoard Member2020 — 2021
- VirbacProject Monitor2018Nice Area, France
- CNRSResearcher2012 — 2017Nice Area, France
- CNRSPhD fellow2005 — 2011
- Norges forskningsrådPhD fellow2006 — 2011
- Sars International Centerresearch2000 — 2006
- Sars International Center for Marine Molecular BiologyResearch assistent2003 — 2005
Skills & more
+4 more
FrenchEnglishNorwegianDrosophilaLanguages English · French · Norwegian
From Marianne's professional profile.
Investments
Per curated public sources.
Colleagues at 3B Future Health Fund
Network2
Investors connected to Marianne in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Marianne Bjørdal?
- Marianne Bjørdal is a Partner at 3B Future Health Ventures, part of the Helsinn Group. She has a background in life science research and investment management, with focus on drug development and early-stage ventures.
- Where does Marianne Bjørdal work?
- Marianne Bjørdal is General Partner at 3B Future Health Fund and Board director at Gain Therapeutics.
- What check size does Marianne Bjørdal write?
- Marianne Bjørdal typically writes checks of $100K – $5M.
- What companies has Marianne Bjørdal invested in?
- Investments tracked here include Epsilogen, GenEp, Navion Neurosciences, Sibylla.
- Where did Marianne Bjørdal go to school?
- Marianne Bjørdal studied at Université Côte d'Azur (Doctor of Philosophy (Ph.D.), Developmental and cellular biology); IAE Nice (Graduate School of Management) (Master of Business Administration - MBA); University of Bergen (UiB) (Cand. scient, Molecular biology).
Same school
Also attended Université Côte d'Azur29
+ 23 more
Also attended IAE Nice (Graduate School of Management)4
Also attended University of Bergen (UiB)43
+ 37 more
